Molecular Basis for Omapatrilat and Sampatrilat Binding to Neprilysin-Implications for Dual Inhibitor Design with Angiotensin-Converting Enzyme. (2020)

First Author: Sharma U

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.0c00441

PubMed Identifier: 32337993

Publication URI: http://europepmc.org/abstract/MED/32337993

Type: Journal Article/Review

Volume: 63

Parent Publication: Journal of medicinal chemistry

Issue: 10

ISSN: 0022-2623